Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Figlin RA et al. - The baseline status of the molecular markers PTEN and HIF1 alpha did not correlate with efficacy in renal cell carcinoma patients treated with temsirolimus versus IFN. Patients demonstrated OS and progression-free survival benefit when treated with temsirolimus regardless of PTEN and HIF1 alpha status.
Robert A. Figlin, 06/16/09
| Although this study did not demonstrate a correlation with response and survival for the biomarkers tested, it remains a high priority for all trials in renal cell carcinoma to identify and test the validity of a biomarker to predict biologic behavior. |
Related Articles
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 83%
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 83%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 83%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 83%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Conditionally immortalized human podocyte cell lines established from urine
American Journal of Physiology: Renal Physiology, 12/04/09
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/04/09
Familiality of kidney stone disease in Iceland
Scandinavian Journal of Urology and Nephrology, 12/04/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Birt-Hogg-Dube syndrome: diagnosis and management
The Lancet Oncology, 12/04/09
Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram
Journal of Clinical Oncology, 12/04/09
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
European Urology, 12/04/09
Article Search
Sponsor


See Latest Articles


